Use of chemotherapy and loco-regional therapy in stage IA triple-negative breast cancer and their association with oncologic outcomes: A cancer registry study

We aimed to evaluate the role of adjuvant chemotherapy and loco-regional therapy for stage IA (pT1, pN0) triple-negative breast cancer (TNBC) in a real-world setting. We identified patients with pT1, pN0 TNBC diagnosed between 2009 and 2021 within the Baden-Württemberg cancer registry (BWCR), Germa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pfob, André (VerfasserIn) , Surovtsova, Irina (VerfasserIn) , Kokh, Daria B. (VerfasserIn) , Heil, Jörg (VerfasserIn) , Banys-Paluchowski, Maggie (VerfasserIn) , Morakis, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [18 September 2024]
In: International journal of cancer
Year: 2025, Jahrgang: 156, Heft: 3, Pages: 587-597
ISSN:1097-0215
DOI:10.1002/ijc.35189
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ijc.35189
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.35189
Volltext
Verfasserangaben:André Pfob, Irina Surovtsova, Daria B. Kokh, Baden-Württemberg Cancer Registry (BWCR), Joerg Heil, Maggie Banys-Paluchowski, Philipp Morakis

MARC

LEADER 00000naa a2200000 c 4500
001 1930055420
003 DE-627
005 20250709103136.0
007 cr uuu---uuuuu
008 250709s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.35189  |2 doi 
035 |a (DE-627)1930055420 
035 |a (DE-599)KXP1930055420 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pfob, André  |e VerfasserIn  |0 (DE-588)1167798945  |0 (DE-627)1031607064  |0 (DE-576)51127338X  |4 aut 
245 1 0 |a Use of chemotherapy and loco-regional therapy in stage IA triple-negative breast cancer and their association with oncologic outcomes  |b A cancer registry study  |c André Pfob, Irina Surovtsova, Daria B. Kokh, Baden-Württemberg Cancer Registry (BWCR), Joerg Heil, Maggie Banys-Paluchowski, Philipp Morakis 
264 1 |c [18 September 2024] 
300 |b Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.07.2025 
520 |a We aimed to evaluate the role of adjuvant chemotherapy and loco-regional therapy for stage IA (pT1, pN0) triple-negative breast cancer (TNBC) in a real-world setting. We identified patients with pT1, pN0 TNBC diagnosed between 2009 and 2021 within the Baden-Württemberg cancer registry (BWCR), Germany. Overall survival (OS) was assessed using Kaplan-Meier statistics and multivariate Cox regression models (adjusted for age, use of chemotherapy, local therapy (breast conserving therapy [breast conserving surgery + radiotherapy] vs. mastectomy), and tumor histologic subtype). A total of 1231 patients with a median follow-up of 45.9 months were identified: 1.0% (12 of 1231) with pT1mi stage, 9.5% (117 of 1231) with pT1a, 23.7% (292 of 1231) with pT1b, and 65.8% (810 of 1231) with pT1c. Multivariate Cox regression analysis revealed no significant influence for the use of chemotherapy on OS in pT1b patients (HR 0.90, 95% CI 0.43-1.90). For pT1c patients with Grade 1-2 tumors, the use of chemotherapy was not significantly associated OS (HR 1.01, 95% CI 0.48-2.11) but breast conserving therapy was associated with improved OS (HR 0.41, 95% CI 0.18-0.93). For pT1c patients with Grade 3 tumors, the use of chemotherapy (HR 0.51, 95% CI 0.33-0.78) as well as breast conserving therapy (HR 0.42, 95% CI 0.23-0.76) was associated with OS. This data suggests that OS in stage IA TNBC is strongly influenced by local therapy rather than the use of chemotherapy, except for pT1c patients with Grade 3 tumors. Larger studies with longer-term follow-up are welcomed to fully inform this discussion. 
650 4 |a breast cancer 
650 4 |a cancer registry 
650 4 |a chemotherapy 
650 4 |a triple-negative breast cancer 
700 1 |a Surovtsova, Irina  |e VerfasserIn  |4 aut 
700 1 |a Kokh, Daria B.  |e VerfasserIn  |4 aut 
700 1 |a Heil, Jörg  |d 1978-  |e VerfasserIn  |0 (DE-588)132580187  |0 (DE-627)52396160X  |0 (DE-576)299238679  |4 aut 
700 1 |a Banys-Paluchowski, Maggie  |e VerfasserIn  |4 aut 
700 1 |a Morakis, Philipp  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 156(2025), 3, Seite 587-597  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Use of chemotherapy and loco-regional therapy in stage IA triple-negative breast cancer and their association with oncologic outcomes A cancer registry study 
773 1 8 |g volume:156  |g year:2025  |g number:3  |g pages:587-597  |g extent:11  |a Use of chemotherapy and loco-regional therapy in stage IA triple-negative breast cancer and their association with oncologic outcomes A cancer registry study 
856 4 0 |u https://doi.org/10.1002/ijc.35189  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.35189  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250709 
993 |a Article 
994 |a 2024 
998 |g 132580187  |a Heil, Jörg  |m 132580187:Heil, Jörg  |d 50000  |d 910000  |d 910400  |e 50000PH132580187  |e 910000PH132580187  |e 910400PH132580187  |k 0/50000/  |k 0/910000/  |k 1/910000/910400/  |p 4 
998 |g 1167798945  |a Pfob, André  |m 1167798945:Pfob, André  |d 910000  |d 910400  |e 910000PP1167798945  |e 910400PP1167798945  |k 0/910000/  |k 1/910000/910400/  |p 1  |x j 
999 |a KXP-PPN1930055420  |e 4744225608 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"subtitle":"A cancer registry study","title_sort":"Use of chemotherapy and loco-regional therapy in stage IA triple-negative breast cancer and their association with oncologic outcomes","title":"Use of chemotherapy and loco-regional therapy in stage IA triple-negative breast cancer and their association with oncologic outcomes"}],"person":[{"display":"Pfob, André","given":"André","family":"Pfob","role":"aut"},{"display":"Surovtsova, Irina","given":"Irina","family":"Surovtsova","role":"aut"},{"role":"aut","display":"Kokh, Daria B.","given":"Daria B.","family":"Kokh"},{"display":"Heil, Jörg","given":"Jörg","family":"Heil","role":"aut"},{"role":"aut","display":"Banys-Paluchowski, Maggie","given":"Maggie","family":"Banys-Paluchowski"},{"family":"Morakis","given":"Philipp","display":"Morakis, Philipp","role":"aut"}],"recId":"1930055420","origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"[18 September 2024]"}],"name":{"displayForm":["André Pfob, Irina Surovtsova, Daria B. Kokh, Baden-Württemberg Cancer Registry (BWCR), Joerg Heil, Maggie Banys-Paluchowski, Philipp Morakis"]},"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1966 -"],"titleAlt":[{"title":"Predictive oncology"}],"language":["eng"],"recId":"269532781","disp":"Use of chemotherapy and loco-regional therapy in stage IA triple-negative breast cancer and their association with oncologic outcomes A cancer registry studyInternational journal of cancer","note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"part":{"text":"156(2025), 3, Seite 587-597","volume":"156","year":"2025","pages":"587-597","extent":"11","issue":"3"},"id":{"issn":["1097-0215"],"doi":["10.1002/(ISSN)1097-0215"],"zdb":["1474822-8"],"eki":["269532781"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer","title":"International journal of cancer"}],"corporate":[{"display":"International Union against Cancer","role":"isb"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"origin":[{"dateIssuedKey":"1966","publisherPlace":"Bognor Regis","publisher":"Wiley-Liss","dateIssuedDisp":"1966-"}]}],"note":["Gesehen am 09.07.2025"],"physDesc":[{"extent":"11 S.","noteIll":"Diagramme"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1930055420"],"doi":["10.1002/ijc.35189"]}} 
SRT |a PFOBANDRESUSEOFCHEMO1820